GOP lawmaker loses nearly $17 million after pharma stock tanks 92%

The Office of Congressional Ethics is investigating Collins' role as an Innate investor, according to the Buffalo News.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.